These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 8395981)
1. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues. Berggren MI; Gallegos A; Dressler LA; Modest EJ; Powis G Cancer Res; 1993 Sep; 53(18):4297-302. PubMed ID: 8395981 [TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues. Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723 [TBL] [Abstract][Full Text] [Related]
4. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220 [TBL] [Abstract][Full Text] [Related]
5. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1. Samadder P; Richards C; Bittman R; Bhullar RP; Arthur G Anticancer Res; 2003; 23(3B):2291-5. PubMed ID: 12894505 [TBL] [Abstract][Full Text] [Related]
6. ET-18-OCH3 inhibits the phosphorylation and activation of p70 S6 kinase in MCF-7 cells. Arthur G; Samadder P; Bittman R Anticancer Res; 2005; 25(1A):95-100. PubMed ID: 15816524 [TBL] [Abstract][Full Text] [Related]
7. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. Chabot MC; Wykle RL; Modest EJ; Daniel LW Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333 [TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor stimulates synthesis of PtdIns(3,4,5)P3 by activating a PtdIns(4,5)P2 3-OH kinase. Hawkins PT; Jackson TR; Stephens LR Nature; 1992 Jul; 358(6382):157-9. PubMed ID: 1319558 [TBL] [Abstract][Full Text] [Related]
9. Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells. Dive C; Watson JV; Workman P Cancer Res; 1991 Feb; 51(3):799-806. PubMed ID: 1988120 [TBL] [Abstract][Full Text] [Related]
10. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes. Samadder P; Arthur G Cancer Res; 1999 Oct; 59(19):4808-15. PubMed ID: 10519389 [TBL] [Abstract][Full Text] [Related]
11. Cell kill and cytostasis by ET-18-OCH3 and heat. Fujiwara K; Modest EJ; Wallen CA Anticancer Res; 1995; 15(4):1333-8. PubMed ID: 7654017 [TBL] [Abstract][Full Text] [Related]
12. Advances with phospholipid signalling as a target for anticancer drug development. Powis G; Berggren M; Gallegos A; Frew T; Hill S; Kozikowski A; Bonjouklian R; Zalkow L; Abraham R; Ashendel C Acta Biochim Pol; 1995; 42(4):395-403. PubMed ID: 8852330 [TBL] [Abstract][Full Text] [Related]
13. Characterization of phosphatidylinositol and phosphatidylinositol-4-phosphate kinases in human neutrophils. Pike MC; Arndt C J Immunol; 1988 Mar; 140(6):1967-73. PubMed ID: 2831274 [TBL] [Abstract][Full Text] [Related]
14. 1-O-octadecyl-2-O-methyl-glycerophosphocholine inhibits the transduction of growth signals via the MAPK cascade in cultured MCF-7 cells. Zhou X; Lu X; Richard C; Xiong W; Litchfield DW; Bittman R; Arthur G J Clin Invest; 1996 Aug; 98(4):937-44. PubMed ID: 8770865 [TBL] [Abstract][Full Text] [Related]
15. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro. Cardile V; Mascarucci P; De Simoni MG; Jiang X; Bindoni M Cytokine; 1996 Sep; 8(9):698-701. PubMed ID: 8932980 [TBL] [Abstract][Full Text] [Related]
16. Glycosylated antitumor ether lipids are more effective against oncogene-transformed fibroblasts than alkyllysophospholipids. Samadder P; Byun HS; Bittman R; Arthur G Anticancer Res; 1998; 18(1A):465-70. PubMed ID: 9568121 [TBL] [Abstract][Full Text] [Related]
17. Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine. Ahmad I; Filep JJ; Franklin JC; Janoff AS; Masters GR; Pattassery J; Peters A; Schupsky JJ; Zha Y; Mayhew E Cancer Res; 1997 May; 57(10):1915-21. PubMed ID: 9157985 [TBL] [Abstract][Full Text] [Related]
18. Effects of ether lipid 1-O-octadecyl-2-methoxy-rac-glycero- 3-phosphocholine and its analogs PAF and CPAF on the release of nitric oxide in primary cultures of rat astrocytes. Cardile V; Jiang X; Renis M; Bindoni M Brain Res; 1996 Apr; 715(1-2):98-103. PubMed ID: 8739627 [TBL] [Abstract][Full Text] [Related]
19. The antitumor ether lipid edelfosine (ET-18-O-CH3) induces apoptosis in H-ras transformed human breast epithelial cells: by blocking ERK1/2 and p38 mitogen-activated protein kinases as potential targets. Na HK; Surh YJ Asia Pac J Clin Nutr; 2008; 17 Suppl 1():204-7. PubMed ID: 18296338 [TBL] [Abstract][Full Text] [Related]
20. Dissociation of the effects of the antitumour ether lipid ET-18-OCH3 on cytosolic calcium and on apoptosis. Alonso MT; Gajate C; Mollinedo F; Modolell M; Alvarez J; García-Sancho J Br J Pharmacol; 1997 Aug; 121(7):1364-8. PubMed ID: 9257915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]